header logo image


Page 1,054«..1020..1,0531,0541,0551,056..1,0601,070..»

‘Can’t Pay? We’ll Take It Away’ Star Reveals ‘Death Sentence’ – Unilad – UNILAD

April 25th, 2017 4:52 am

The star ofCant Pay? Well Take It Away!has revealed he desperately needs a bone marrow transplant after being diagnosed with terminal cancer.

TV bailiff Delroy Anglin has an aggressive form of leukaemia which hes called a death sentenceunless a donor an be found.

The 56-year-old father of five is currently undergoing chemotherapy at the Royal Marsden in Sutton to battle the worst symptoms of the disease but the treatment will only be effective for so long.

Delroy has spoken about the toll that chemo has taken on his body, saying:

Chemotherapy is tough. The first time I had it I was in a wheelchair after. I looked in the mirror and didnt even recognise myself, I was so weak and frail.

The next time I forced myself to take a few steps, and not let it do that to me again. Now Im feeling positive about it. But it wont go away. A transplant would be a game changer. Its the only way to get rid of it.

Unfortunately The Croydon Advertiser have reported that finding a donor will be difficult due to Delroys minority background as there arent manydonors with African Caribbean heritage on the donor register.

Delroys life has changed significantly since the diagnosis and hes been forced to quit his on-screen work for Channels 5s Cant Pay? Well Take It Away!

He said:

You feel as if someone has pronounced a death sentence. Life changed in an instant. When they tell you, youre just hoping someone has made a mistake, but they havent.

At the end of the day, unless somebody says differently Im terminal.

Mr Anglin is suffering from a specific type of leukaemia called Acute myeloid leukaemia (AML) whichaffects the stem cells in bone marrow and causes a huge amount of white blood cells to be produced, reducing the number of red cells in the body.

Only half of patients can be cured of the rare disease but despite the debilitating effects Delroy remains hopeful he can beat it and his family have rallied around him to support him during this difficult time.

In order to help save Delroys life the campaign#Match4Delroy has been launched by blood cancer charity the African Caribbean Leukaemia Trust (ACLT) to encourage people to join the donor register.

Here is the original post:
'Can't Pay? We'll Take It Away' Star Reveals 'Death Sentence' - Unilad - UNILAD

Read More...

How Minnesota researchers are helping to heal broken hearts: BTN LiveBIG – Big Ten Network

April 25th, 2017 4:52 am

A heart attack occurs when one or more of the coronary arteries feeding oxygen-rich blood to the heart muscle become blocked, cutting off the supply and leading to severe pain, tissue death and possible loss of life. Heart attack victims are left with varying degrees of damage to the muscle, and that damage can lead to complications and impaired function down the road.

A new heart patch, though, aims to reverse a large portion of the damage heart attacks leave behind. Developed by a team led by University of Minnesota biomedical engineers, the patch is made from heart stem cells and has been found to be effective in helping heal scar tissue and regrowing healthy heart muscle.

This is a significant step forward in treating the No. 1 cause of death in the U.S., said Brenda Ogle, an associate professor of biomedical engineering at the University of Minnesota, speaking with universitys news service. We feel that we could scale this up to repair hearts of larger animals and possibly even humans within the next several years.

Created using laser-based 3D printing, the patch is a matrix of human heart stem cells and proteins that fully integrates into the heart. When tested on a mouse heart after a simulated heart attack, the patch helped to speed recovery and function in just four weeks.

While the breakthrough is still in its earliest phases of testing, the team, which includes the University of Wisconsin-Madison, is hoping to scale up the project in the near future. Ogle envisions the rollout of a human-ready version of the patch could happen in as little as four years.

Below is a video of the patch cells beating

Go here to see the original:
How Minnesota researchers are helping to heal broken hearts: BTN LiveBIG - Big Ten Network

Read More...

Mexico Eliminates Infectious Disease Which Is Leading Cause of … – NBCNews.com

April 25th, 2017 4:52 am

In a significant public health victory, Mexico has succeeded in eliminating a disease which is the leading cause of blindness worldwide.

The Pan American Health Organization (PAHO) and the World Health Organization (WHO) announced Monday that Mexico is the first country in the Americas to eliminate trachoma as a public health issue. The disease, caused by a bacteria, affects the eye and repeated infections can lead to scarring and even loss of vision.

It primarily affects young children, and can be spread by personal contact or by flies that that have been in contact with the discharge from the eyes or nose of an infected person.

"This is a historic moment for public health in Mexico and the Americas," said Carissa F. Etienne, Director of the Pan American Health Organization (PAHO), WHO regional office for the Americas. "Eliminating a disease is not achieved every day."

Trachoma primarily affects poor and isolated populations in 41 countries; in the Americas, the disease is still prevalent in Brazil, Guatemala, and Colombia.

Mexico has become the third country, after Oman and Morocco, to receive WHO validation for eliminating the disease.

Related: Measles Has Been Eliminated in the Americas, WHO Says

In Mexico, trachoma affected over 146,000 people. The country ramped up its actions in 2004 with the creation of the Trachoma Prevention and Control Program of the Ministry of Health of Chiapas and the strengthening of the WHO SAFE strategy. The "Trachoma Brigades" focused on cleanliness, antibiotics, environmental improvement and surgery for the advanced stage of the disease.

Related: 'Adis Zika!' Elmo Teaches Kids in Caribbean, Latin America about Zika

The program's slogan was "With water, soap and cleanliness you can prevent trachoma." Teachers at schools would also meet with parents regularly to promote better hygiene.

The international criteria for the elimination of trachoma as a public health problem includes prevalence of less than 5 percent in children aged 1 to 9, and less than one case of trachomatous trichiasis (inverted eyelashes) per 1,000 inhabitants.

Follow NBC News Latino on Facebook, Twitter and Instagram

Read more:
Mexico Eliminates Infectious Disease Which Is Leading Cause of ... - NBCNews.com

Read More...

India swaps 40-yr-old definition of blindness for WHO criteria: Move may allow blanket discrimination against … – Firstpost

April 25th, 2017 4:52 am

Last week, as per a notification issued by the Union Health Ministry, India embraced the World Health Organisations (WHO) definition of blindness, and changed its four-decade old criteria of what blindness should be. In the process, India would drastically bring down the number of people who will be considered blind in the country.

Image used for representational purpose only.

The new definition suggests that a person who is unable to count fingers from a stipulated distance of three metres would be regarded as blind. The earlier definition of blindness, adopted in 1976, had a prerequisite of six metres. With the implementation of the new definition, the number of blind people would reduce from 1.20 crore to 80 lakh, according to the National Blindness survey 2007.

The rationale for the erstwhile definition of blindness was to include economic blindness cases that impede a persons ability to earn wages, while the WHO criteria includes people who have social blindness, which hampers the day to day interactions in a persons life.

The definition was revised so that comparable data could be generated so as to analyse it against global estimates and achieve the attain the WHO objective of reducing the prevalence of India to 0.3% of the total population by 2020.

Keeping this move in mind, the name of the government scheme that targets the blind population has been changed from the National Programme for Control of Blindness to the The National Programme for Control of Blindness and Visual Impairment, and its focus would be on both blind as well as visually impaired people.

Deputy Director General of National Programme for Control of Blindness (NPCB), Dr Promila Gupta, stated, Because of the earlier definition, we were projecting a higher figure of blind people from India at any international forum, presenting ourselves in poor light.

It is important to assess this decision of the Union Health Ministry in order to understand how this will impact the blind population legally. India ratified the United Convention on Rights of Persons with Disabilities (CRPD) in 2007. However, the domestic legislation that protects the rights of disabled persons, The Rights of Persons with Disabilities Act, 2016, was only passed in December.

This new legislation would replace The Persons with Disabilities (Equal Opportunities, Protection of Rights and Full Participation) Act, 1995, which would be repealed. The Persons with Disabilities Act was inadequate in recognising the rights enunciated within the CRPD, and did not codify or mention basic CRPD principles of legal capacity and reasonable accommodation.

While the new Act includes a number of new conditions in the disabilities list, it retains blindness as a disability, along with 21 other conditions, and a power to the central government for adding more types of conditions, if required. Low vision is also another condition in this list. The Act casts a responsibility upon appropriate governments to take effective measures to ensure that the persons with disabilities enjoy their fundamental rights equally with others.

The new Act most importantly codifies the principle of reasonable accommodation within the clause that defines discrimination. Section 2 (h) defines discrimination thus discrimination in relation to disability, means any distinction, exclusion, restriction on the basis of disability which is the purpose or effect of impairing or nullifying the recognition, enjoyment or exercise on an equal basis with others of all human rights and fundamental freedoms in the political, economic, social, cultural, civil or any other field and includes all forms of discrimination and denial of reasonable accommodation. It also defines reasonable accommodation as does the CRPD means necessary and appropriate modification and adjustments, without imposing a disproportionate or undue burden in a particular case, to ensure to persons with disabilities the enjoyment or exercise of rights equally with others.

Keeping the new understanding of blindness in India, it is vital to question whether this decision would affect the legal capacity and fundamental freedoms of the 40 lakh population that was regarded as legally blind before this Health Ministry directive, but now have ceased to be so because of a new definition of the disability. How would this affect their employment and capacity to earn a livelihood? And most significantly, how would this affect the way reasonable accommodation is invoked for the blind?

In Pranay Kumar Poddar v. State of Tripura and Others (2017), the Supreme Court asked some very pertinent questions regarding blindness and employment in the medical practice. The bench comprising Justice Dipak Misra and Justice AM Khanwilkar directed the Medical Council of India to constitute a committee of experts to look into the areas of practice that MBBS aspirants with colour blindness could engage in.

The bench also stated that it was an obligation of the Medical Council of India to look into and take progressive measure so that an individual suffering from CVD may not feel like an alien to the concept of equality, which is the fon juris of our Constitution. The amicus curiae, Mr Vishwanathan, argued that since colour blindness was not regarded as a disability under the Persons with Disabilities Act, 1995 or the Rights of Persons with Disabilities Act 2016, there needs to be an examination of the nature and severity of colour blindness and the corresponding subjects they can practice.

The Supreme Court stated: Total exclusion for admission to medical courses without any stipulation in which they really can practice and render assistance would tantamount to regressive thinking. The march of science, apart from our constitutional warrant and values, commands inclusion and not exclusion. That is the way a believer in human rights should think.

In the case of Ashutosh Kumar v. Film and Television Institute of India (2017), the Bombay High Court upheld the rules laid down the Film and Television Institute of India (FTII) that stated that candidates suffering from colour blindness would not be suitable for the course. The Division Bench of Justice Shantanu Kemkar and Justice Prakash Naik rejected the petition of Ashutosh Kumar who was denied admission for a post-graduate course on editing at the Institute.

The court stated that the rules of FTII must be upheld and that the Ashutosh was suffering from colour blindness, and that there was no malafide or arbitrariness in the rules or the recommendations of the expert committee of the Institute. A Delhi High Court case of 2013 adjudicated that colour blindness was not a ground for denying promotion, and directed government authorities to treat CRPF personnel with colour blindness on par with others for promotion.

In Bhagwan Dass and Anr v. Punjab State Electricity Board (2008), the appellant had become completely blind during his service, and the respondent had categorically refused to accommodate him in an alternate position, and instead terminated his service according to the Persons with Disabilities Act.

The Supreme Court, in the case, took a protective view of persons with disabilities and reiterated the judgment in Kunal Singh v. Union of India: In construing a provision of a social beneficial enactment that too dealing with disabled persons intended to give them equal opportunities, protection of rights and full participation, the view that advances the object of the Act and serves its purpose must be preferred to the one which obstructs the object and paralyses the purpose of the Act.

The judgments discussed indicate that there is not a contextual understanding or nuancing of how blindness is perceived in a legal sphere: This means that there is no pattern of adjudicating upon blindness and its relationship with legal rights and the principle reasonable accommodation at the workplace.

With the change in definition of blindness, this nuance is likely to get more difficult and as a result of this, several lakh people may be affected adversely. Changing the definition of blindness, without putting in place proper systems, has created a dangerous situation where blanket discrimination against the visually impaired may take place by both government as well as private actors.

Originally posted here:
India swaps 40-yr-old definition of blindness for WHO criteria: Move may allow blanket discrimination against ... - Firstpost

Read More...

Uber CEO: Travis Kalanick built Uber into a multibillion-dollar giant … – News & Observer

April 25th, 2017 4:52 am

News & Observer
Uber CEO: Travis Kalanick built Uber into a multibillion-dollar giant ...
News & Observer
In a quest to build Uber into the world's dominant ride-hailing entity, Travis Kalanick has openly disregarded many rules and norms, backing down only when ...
Travis Kalanick Plays the Mythic Role of the Rebel CEO Too WellThe Ringer (blog)
Uber chief executive Travis Kalanick plays with fireThe New Daily
Uber's CEO Plays With FireNew York Times
TechCrunch -The Verge
all 193 news articles »

See the article here:
Uber CEO: Travis Kalanick built Uber into a multibillion-dollar giant ... - News & Observer

Read More...

[ April 25, 2017 ] World Earth Day: Stakeholders canvass for adoption of biotechnology for food security Agriculture – NIGERIAN TRIBUNE (press…

April 25th, 2017 4:51 am

NIGERIAN TRIBUNE (press release) (blog)
[ April 25, 2017 ] World Earth Day: Stakeholders canvass for adoption of biotechnology for food security Agriculture
NIGERIAN TRIBUNE (press release) (blog)
The Head of Agriculture Division of the ECOWAS Commission, Ernest Aubee, who spoke with Nigerian Tribune, said the ECOWAS has a biotechnology technology action plan which it is currently implementing across the 15 member states. The Nigerian ...

See more here:
[ April 25, 2017 ] World Earth Day: Stakeholders canvass for adoption of biotechnology for food security Agriculture - NIGERIAN TRIBUNE (press...

Read More...

NutriBullets SuperFood Boost Featuring Plandai Biotechnology’s … – Marketwired (press release)

April 25th, 2017 4:51 am

LONDON, UNITED KINGDOM--(Marketwired - Apr 24, 2017) - Planda Biotechnology, Inc. (OTCQB: PLPL) ("Planda" or "the Company"), producer of the highly bioavailable Phytofare Catechin Complex, today announced that NutriBullet SuperFood Fat Burning Boost featuring Planda's Phytofare Catechin Complex will be available at retail outlets across the United States as early as May 2017.As announced last November, Capital Brands, the makers of NutriBullet SuperFoods, will now be featuring Planda's Phytofare Catechin Complex as the active ingredient in their product, SuperFood Fat Burning Boost.Capital Brands is expected to launch the revised product containing Phytofare with their retailers and on their website (nutriliving.com) as early as next month.

Callum Cottrell-Duffield, Chief Operating Officer for Planda Biotechnology, commented, "We are excited to have Phytofare associated with such a fantastic brand as Nutribullet. Their use of Phytofare as an active ingredient in their reformulation is a clear indication of their commitment to use only the best ingredients to ensure that their customers receive a supremely effective product. It is also testimony to our shareholders that we are indeed on the right track and that our Phytofare ingredients are game changers for the supplement industry."

NutriBullet has formulated specialized, plant-based SuperFood products using a variety of plant proteins,prebiotic and other dietary fibers, proprietary spice blends, and other unique ingredients etc. that can be easily combined into healthy smoothies using their industry-leading nutrient extraction blenders. The company uses all GMO-free ingredients sourced from the world's most reputable farms that undergo extensive testing for purity, effectiveness and flavor.

Planda operates an 8,000-acre estate in Mpumalanga, South Africa, where it grows and processes the green tea used in its Phytofare products. The company uses solar power for on-site housing and organic, sustainable farming practices to ensure the highest quality. Between the farm and factory, the company provides employment for hundreds of local families and, through profit sharing and rental payments, is able to bring economic value to the Zulu community.

About Capital Brands LLC Capital Brands LLC and its subsidiaries create, produce, and sell NutriBullet blenders as well as SuperFood formula mixes and other accessories for their blenders that help give the consumer the best possible health benefits using only the best and most quality ingredients available. The company focuses on nutrient extraction in order to deliver the most nutrients possible from food and other ingredients to increase the health of people everywhere. For more information, please visit https://www.nutribullet.com/."NutriBullet" and "SuperFood Fat Burning Boost" are the registered trademarks of Capbran Holdings, LLC.

About Planda Biotechnology, Inc. Planda Biotechnology, Inc. and its subsidiaries develop highly phyto-available extracts. Planda Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.

Safe Harbor Statement This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.

See the original post here:
NutriBullets SuperFood Boost Featuring Plandai Biotechnology's ... - Marketwired (press release)

Read More...

Vetr Inc. Downgrades iShares NASDAQ Biotechnology Index (IBB … – The Cerbat Gem

April 25th, 2017 4:51 am

BBNS
Vetr Inc. Downgrades iShares NASDAQ Biotechnology Index (IBB ...
The Cerbat Gem
iShares NASDAQ Biotechnology Index (NASDAQ:IBB) was downgraded by Vetr from a buy rating to a hold rating in a research note issued to investors on ...
iShares NASDAQ Biotechnology Index (IBB) Lifted to Buy at Vetr Inc.Sports Perspectives
iShares NASDAQ Biotechnology Index (IBB) Earning Favorable ...BBNS

all 4 news articles »

Follow this link:
Vetr Inc. Downgrades iShares NASDAQ Biotechnology Index (IBB ... - The Cerbat Gem

Read More...

34 Natural Remedies for Rheumatoid Arthritis, Some of Which Are Based on a Personal Experience – eMaxHealth

April 25th, 2017 4:51 am

Rheumatoid Arthritis (RA) is a subject near and dear to my heart. Twenty years ago, my daughter who had essentially been sick since she weaned herself from the breast at 10 months old, was chronically ill from that time on. One month wed be in the pediatricians office for an ear infection and the next a sore throat. The overuse of antibiotics by her doctors without any type of sensitivity test to determine what antibiotic would be most effective bordered on malpractice. Eventually nothing worked. At 13, she not only had one of her recurring strept throat infections, this time it turned into an auto-immune disease known as Erythema nodosum (EN). The disease presented with small lumps along her shins about the size of a pea that were bright red and hot. Within a few days these lumps began to grow in diameter and were extremely painful. Medical books described he pain as exquisite. Finally the lumps would take on the appearance of bruises. We were living out of state at the time, and I felt moving home to doctors I knew was warranted. I took her to her regular pediatrician who examined her, left the room to do some research and them came back to give me a diagnosis. Susanna, I think this is Erythema nodosum. It could resolve in a few weeks, a few months, or years. As luck would have it, my daughters case was lengthy, lasting 7 years and leaving her with other health issues including arrhythmias, depression, and juvenile rheumatoid arthritis (JRA).

Many of the allopathic treatments my daughter underwent were worse than the disease itself. Pain killers were addicting, epidural steroid shots caused fainting and back pain which she suffers from to this day, some of the anti-depressants caused the very issue we were trying to cure (Erythema nodosum) as well as suicidal ideation, and overuse of antibiotics completely knocked out her immune system.

Out of desperation I did my own research and discovered Thalidomide, the 1950s and 60s drug used to treat morning sickness in pregnant women was being used in the treatment of Hansens disease also known as leprosy (Erythema nodosum leprosum). I made the intuitive leap that Thalidomide might also work in EN. However, Thalidomide caused severe birth defects. While in the process of securing permission to use the drug, she went into remission.

Finally I met a doctor in Hawaii who told me she used potassium iodide to treat Erythema nodosum and that is was effective 99% of the time. Yet out of the 8-10 specialists we had seen, not one suggested this simple treatment. About that time, my daughter was thought to have breast cancer and had just had a baby so in the confusion, that simple treatment was forgotten.

Although the primary symptoms of the EN stopped once she was in remission, the secondary symptoms of RA, severe pain and inflammation with decreased mobility persisted. When she was 29 I discovered a product called LIMU which contained fucoidan, organic iodine, vitamins, minerals, enzymes, and fatty acids that was a complete nutritional and immune system boost. Within a matter of days she felt better and had improved mobility. Within 6 weeks she was pain free for the first time in almost 17 years. I began to do extensive research on brown seaweed and everything began to make perfect sense. In September my daughter will be 34 and she remains symptom free.

Arthritis is a debilitating auto-immune disease process that strikes about 1% of the population. Causes may include viral, bacterial, or mycoplasma infections so the underlying cause must be alleviated. While there are pharmaceuticals for the treatment of RA, they are not without serious side effects, especially biologics which lower immune function.

I have compiled an extensive list of natural options for Rheumatoid Arthritis. Those marked with an asterisk are what I personally consider most effective.

1. *Water Water is one of the most overlooked nutrients when it comes to health. Some people dont drink enough and some people dont drink water at all. Our bodies are about 60% water so its essential for life, organ function, removal of toxins and joint health. Here also see these home remedies to naturally reduce gout and arthritis pain.

More here:
34 Natural Remedies for Rheumatoid Arthritis, Some of Which Are Based on a Personal Experience - eMaxHealth

Read More...

Arthritic Alberta jaguar treated with cutting-edge human procedure – CBC.ca

April 25th, 2017 4:51 am

A jaguar is recovering from an unique arthritis procedure after a podiatricsurgeon saw the big cat in an Alberta zoo.

Mia a 14-year-old male at the Discovery Wildlife Park near Innisfail is likely the first jaguar to have the procedure, which is usually reserved for humans.

Dr. Karim Ravji, who runs a private orthobiologics clinic in Edmonton, noticed the jaguar's poor health during a visit to the zoo last summer.

"The groundhogs would actually come and taunt it and steal its food and stuff. This beautiful, majestic animal could not leap or pounce and actually was lying there in pain," he told The Calgary Eyeopener.

Ravji talked to zoo owner Doug Bosabout Mia, who has arthritis in his two front knees.

"We were relieving the pain from that with medication, but the medication is just really hard on the animal. It shortens their life span up dramatically. It affects the kidneys and the liver and all that sort of stuff," said Bos.

Ravji consulted with animal experts and found two veterinarians who could help with drawing plasma, spinning off the platelets, and then re-injecting them into Mia's front kneesin hopes of reducing inflammation and promoting tissue regeneration.

Mia the jaguar is sedated and watched over by (from left) STeM MD nurse Heather Pym and Dr. Karim Ravji and Discovery Wildlife Park animal health technicians Tony Stevens and Holli Duffy. (Heather Pym)

"We supplied them with equipment," he said.

Mia was sedated with a blow dart and then given general anesthesia.

"It's not everyday that we have a patient who could wake up and pounce and kill you," said Ravji.

The jaguar was walking again right after the procedure and seems to be doing better, but it takes eight to 12 weeks to see an improvement, Ravji said.

"It's kind of exciting because if it is really effective then it's kind of breaking ground for other zoos and other animals," added Bos.

Zoo staff, thevets and Ravji's medical group all donated their time, and may try and help other animals at the zoo.

"We would do it again," he said. "There's some grizzly bears that have arthritis and Mia's twin, another jaguar, that's got some tendinitis and arthritis issues. This type of injection can be used for tendon, ligament or joint. You just have to have the proper equipment and a good cell collection."

With files from theCalgaryEyeopener

Link:
Arthritic Alberta jaguar treated with cutting-edge human procedure - CBC.ca

Read More...

Global Stem Cell Therapy Market – Analysis, Technologies and … – PR Newswire (press release)

April 25th, 2017 4:50 am

The global stem cell therapy market to grow at a CAGR of 36.52% during the period 2017-2021.

The report, Global Stem Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is evolution of new destinations in the development of stem cell therapies. Traditionally, the US and European countries are the key destinations for clinical trials for stem cell therapy products. However, the transformation of regulatory landscape in countries such as Japan and South Korea has made these regions as attractive destinations for the development of stem cell therapy products.

According to the report, one of the major drivers for this market is increase in federal funding in stem cell therapy. Research and clinical trials of stem cell therapy require huge investment, which many research institutes and small companies cannot afford. Therefore, many federal organizations provide funding to these institutes and small companies to help their innovative ideas in the development of stem cell therapies. Worldwide, many government organizations have noticed the importance of regenerative medicine, and thus they have allocated funds and grants in that area. For instance, in the US, the NIH and CIRM provide most of the funds.

Key vendors

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Understanding of stem cell therapy

Part 06: Ethical issues and regulatory landscape

Part 07: Key clinical trials

Part 08: Market landscape

Part 09: Market segmentation by therapy

Part 10: Market segmentation by applications

Part 11: Geographical segmentation

Part 12: Market drivers

Part 13: Impact of drivers

Part 14: Market challenges

Part 15: Impact of drivers and challenges

Part 16: Market trends

Part 17: Vendor landscape

Part 18: Key vendor analysis

For more information about this report visit http://www.researchandmarkets.com/research/gdv8s6/global_stem_cell

Media Contact:

Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-stem-cell-therapy-market---analysis-technologies-and-forecasts-to-2021---increasing-demand-to-develop-effective-drugs-for-cardiology-and-degenerative-disorders---research-and-markets-300444066.html

SOURCE Research and Markets

http://www.researchandmarkets.com

Read more:
Global Stem Cell Therapy Market - Analysis, Technologies and ... - PR Newswire (press release)

Read More...

Meet Malikaa Marathe, the girl who went from having partial eyesight to becoming first in tennis – YourStory.com

April 24th, 2017 12:44 pm

Malikaa Marathe, who was partially blind for four years when she was a kid, is now ranked first in the All India Tennis Association (AITA) rankings for girls.

Growing up, Malikaa was like any other child her age, until she was affected by amblyopia or lazy eye. This is a condition where one has vision problems as a result of the brain and eye not working well together. She was affected by amblyopia in her right eye and to strengthen that eye, she had to wear a patch on her left eye according to The Frustrated Indian. She had to do this for four years, which means as part of the treatment she had very poor vision for those years.

For Malikaa it wasnt easy. But she carried on undeterred with only one thing in her mindto excel in her chosen field and become a world-class tennis player. Self-driven and self-motivated, she undergoes training with a determination that is beyond her age.

As a result, in 2017, she is ranked first in the U-14 All India Tennis Association (AITA) rankings for girls. Women entering and succeeding in the field of sports isn't the same as men because they have to break multiple barriers and fight a constant battle against social stigma.

Be it having to wear shorts or spend money on training, it isn't easy in a society where girl children are always seen as a burden and a liability. In a country like India, convincing a family to spend on a girl child is not even the most difficult partaccording to the Youth Ki Awaaz, the Indian government's attitude towards any sport other than cricket is abysmal. This is even more the case when it comes to sports that women are involved in.

We all remember the case ofDipa Karmakar, who nearly did not participate in the Olympic Games because of a lack of funding. In such a scenario, girls like Malikaaact as a constant source of hope for others to emulate.

Do you have an interesting story to share? Please write to us at tci@yourstory.com. To stay updated with more positive news, please connect with us onFacebookandTwitter.

See original here:
Meet Malikaa Marathe, the girl who went from having partial eyesight to becoming first in tennis - YourStory.com

Read More...

Women Face Higher Risk of Blindness Than Men – PR Newswire (press release)

April 24th, 2017 12:44 pm

Whatever the cause, there are a fewunique vision problems women need to watch out formore than men. Dry eye occurs at double the rate in postmenopausal women.3 In general, women are more susceptible to autoimmune diseases than men, many of which affect vision, such as lupus, Sjgren's syndrome and hyperthyroiditis. Also, pregnancy can cause vision changes due to the hormones pregnant women experience.

Good news is most vision loss is preventable. The Academy offers five simple steps to take control of your eye health today:

"Eye exams aren't only about checking a person's visual acuity or sharpness, but also determining the overall health of their eyes," said Rebecca J. Taylor, M.D., clinical spokesperson for the American Academy of Ophthalmology. "We encourage women as well as men to get regular eye care. By making vision a priority today, we can help protect our sight as we age."

To learn more ways to keep your eyes healthy, visit the American Academy of Ophthalmology'sEyeSmartwebsite.

About the American Academy of Ophthalmology The American Academy of Ophthalmology is the world's largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart program provides the public with the most trusted information about eye health. For more information, visit aao.org.

1. National Eye Institute 2. National Eye Institute 3. Am J Ophthalmol.2003 Aug;136(2):318-26.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/women-face-higher-risk-of-blindness-than-men-300443529.html

SOURCE American Academy of Ophthalmology

http://www.aao.org

Read this article:
Women Face Higher Risk of Blindness Than Men - PR Newswire (press release)

Read More...

Eye safety in sports and recreation – Trinidad & Tobago Express

April 24th, 2017 12:44 pm

Eye injuries at sports and recreation can have serious consequences, even leading to loss of sight and an end to a promising career. Of the many sports and recreation-related eye injuries that occur each year, 90 per cent are preventable through use of appropriate protective eyewear. The risk of eye injury can vary depending on the activity. Make sure the level of eye protection you or others in your family use is appropriate for the type of activity. Regular eyeglasses and contact lenses do not offer proper eye protection from injury. If you wear spectacles, the lenses should be made of polycarbonate, an especially tough, non-shattering plastic material. Contact lenses offer no protection against injury and safety glasses or goggles must be used. High-risk sports

Sports-related eye injuries occur more frequently in cricket, basketball, squash, baseball and badminton. Injury may be sustained from equipment eg the ball or from a fellow players limbs or head. In cricket and baseball a helmet with a polycarbonate face mask or wire shield should be worn especially by the wicketkeeper and batsmen. This is very important for young inexperienced players eg under-16 cricketers and when facing up to fast bowlers. Boxing and full-contact martial arts pose an extremely high risk of serious and even blinding eye injuries. There is no satisfactory eye protection for boxing, although thumbless gloves may reduce the number of boxing eye injuries. Approved eye ware should be bought from professional eye care providers. Protective eyewear with polycarbonate lenses is recommended for sports such as basketball, racquet sports, soccer and hockey. Choose eye protectors that have been tested to meet the American Society of Testing and Materials (ASTM) standards or that pass the CSA racquet sports standard. If you already have reduced vision in one eye, consider the risks of injuring the stronger eye before participating in contact or racquet sports, which pose a higher risk of eye injury. Check with your ophthalmologist (Eye MD) to see if appropriate eye protection is available and whether or not participating in contact or racquet sports is advised. Other risky leisure activities

In 2008 a survey conducted by the American Academy of Ophthalmology and the American Society of Ocular Trauma showed that more than 40 per cent of patients treated for eye injuries sustained at home were involved in home repairs, yard work, cleaning and cooking. Use common sense and err on the side of caution, whatever the activity. Consider the risk of flying debris or other objects during activities and wear appropriate eye protection. Remember that eyeglasses arent sufficient protection. Be careful during activities or games involving projectiles and other sharp objects that could create injury if in contact with the eye, eg fishing. If you wear contacts or eyeglasses, pack a back-up form of vision correction during bike trips or other activities where you could lose or shatter a lens. If an eye injury occurs, see an ophthalmologist or go to the hospital emergency room immediately, even if the eye injury appears minor. Delaying medical attention can result in permanent vision loss or blindness.

DO NOT touch, rub or apply pressure to the eye. DO NOT try to remove any object stuck in the eye. For small debris, lift eyelid and ask child to blink rapidly to see if tears will flush out the particle. If not, close the eye and seek treatment. Do not apply ointment or medication to the eye. A cut or puncture wound should be gently covered. Only in the event of chemical exposure, flush with plenty of water. Source of information: The American Academy of Ophthalmology.

Presented as a public service by the Caribbean Eye Institute. Eye related questions can be sent to Caribeyett@icloud.com

See the rest here:
Eye safety in sports and recreation - Trinidad & Tobago Express

Read More...

Diabetes may cause more deaths than previously thought – The Messenger (subscription)

April 24th, 2017 12:43 pm

Four times as many deaths may be caused by diabetes, according to a recent study by Boston University School of Public Health published in the online journal PLOS One.

The study argued that diabetes caused 12 percent of deaths in the U.S. Currently, death certificates indicate that 3.3 percent of deaths in the U.S. are caused by diabetes. If the studys findings prove to be accurate, diabetes would become the third-leading cause of death in the United States, up from the seventh.

According to the Kentucky Behavioral Risk Factor Surveillance Survey, diagnosed diabetes among adults nearly doubled in Kentucky from 6.5 percent to 12.5 percent from 2000 to 2014. Now, one in eight Kentucky adults, or 424,670 people in Kentucky are estimated to have diagnosed diabetes.

In 2015, the rate of diabetes increased again to 13.4 percent. Nationally, nearly 10 percent of people have diabetes.

The Centers for Disease Control estimates 138,000 Kentuckians are living with undiagnosed diabetes.

The Pennyrile region of Kentucky has a comparatively average rate of diabetes, at 12.1 percent. Regions along the eastern part of Kentucky have rates as high as 17.8 percent.

It was surprising to me that they would put it at 3 percent, said Christian County Health Department Nurse Jennifer Boone. Diabetes is just so hard on the entire body. It effects the entire body. All the organ systems, everything.

Diabetes is a group of diseases in which high levels of blood sugar are found in the body for extended periods of time.

Type 1 Diabetes comes from the pancreas failing to produce enough insulin. Type 2 Diabetes is usually caused by obesity and inactivity, when the body does not respond to insulin properly. Type 2 Diabetes usually occurs in later stages in life and is considered a result of lifestyle choices.

Its a lifelong thing. A lot of people think that if they eat healthy, if they exercise, if they are able to come off their medication then they dont have diabetes, Boone said. Its not like its ever really cured. Its just managed well.

Diabetes can cause kidney failure. It can also cause blindness, as the blood vessels in the eye can become damaged by the high amount of blood sugar caused by diabetes.

Gums can also become infected and inflamed by diabetes.

Any open wounds take longer to heal with diabetes, leading to many festering sores for those who suffer from the disease.

Kentucky has the 12th highest mortality rate in America. Exercise and a good diet are considered to be good forms of diabetes prevention.

People with higher than average blood sugar levels are considered to have prediabetes. Those with that condition can prevent diabetes with exercise and a good diet.

The Christian County Health Department advocated for the expansion of the Hopkinsville Greenway System during the debate over H-CC WINS, because the organization believed that the system would promote walking in the community, which would lead to better health.

Read more here:
Diabetes may cause more deaths than previously thought - The Messenger (subscription)

Read More...

Becton Dickinson Aims Beyond Diabetes with $24B Bard Deal – Xconomy

April 24th, 2017 12:43 pm

Xconomy New York

In a medical technology merger with implications for the healthcare sector in the United States and beyond, Becton Dickinson is acquiring C.R. Bard for $24 billion to tap into the growing markets for products used in treating vascular conditions and cancer.

Under the deal announced Sunday, Franklin Lakes, NJ-based Becton Dickinson (NYSE: BD) will pay Bard (NYSE: BCR) shareholders approximately $222.93 in cash and 0.5077 shares of BD stock per Bard share. That represents $317 for each Bard share, a 25.2 percent premium over Bards closing stock price Friday. When the deal closes, shareholders of Murray Hill, NJ-based Bard will own approximately 15 percent of the combined company.

BDs $12.4 billion in revenue last year was split between its Medical Segment, which makes diabetes care products and devices used by clinicians to manage and administer medication, and its Life Sciences Segment that sells products for collecting and transporting diagnostic specimens. The company says that Bard will help it expand beyond diabetes into areas such as peripheral vascular disease, urology, hernia, and cancer.

Bard operates four business units: oncology, vascular, urology, and surgical specialties. Vascular products made up more than $1 billion of the companys $3.7 billion in 2016 revenue, edging out oncology as the companys largest business unit. BD says that bringing Bards vascular products, such as catheters and ports, together with its devices that prepare, dispense, and administer drugs will help the combined entity address a wider range of medication management needs. BD, which conducts its research and development work in Research Triangle Park, NC, also says that the two companies together can offer a more comprehensive lineup of products addressing surgical site infections and catheter-related blood stream infections.

Both companies generate most of their revenue from U.S. customers, but BD notes that Bards head start in international markets, with about 500 products already registered for sale overseas, was attractive.

The combined company will have a large and growing presence in emerging markets, including $1 billion in annual revenue in China, BD said in a prepared statement.

The medical device sector has experienced a flurry of activity in recent years. In 2015, Medtronic (NYSE: MDT) closed on its acquisition of Mansfield, MA-based Covidien for $49.9 billion in cash and stock. Later that year medical device giant Zimmer acquired its Warsaw, IN, neighbor Biomet in a $13.35 billion cash and stock deal that formed Zimmer Biomet (NYSE: ZBH).

BDs Bard deal comes two years after it closed its $12.2 billion acquisition of San Diego-based CareFusion. CareFusion brought to BD its lineup of devices used for administering and managing medication, which were integrated into the New Jersey companys medical division. With the Bard acquisition, BD plans to create a third business unit called BD Interventional. BD says that Tom Polen, who is executive vice president of the BD Medical Segment, will become president of BD, effective immediately. In his new role, Polen will oversee all three of BDs business segments.

The boards of directors of both BD and Bard have approved the deal. The companies expect the acquisition to close in the fall of this year.

Photo by Flickr user Tareq Salahuddinvia a Creative Commons license.

Frank Vinluan is editor of Xconomy Raleigh-Durham, based in Research Triangle Park. You can reach him at fvinluan [at] xconomy.com

Read more from the original source:
Becton Dickinson Aims Beyond Diabetes with $24B Bard Deal - Xconomy

Read More...

Russia Diabetes Market Report: 2017 – 2022 – Research and Markets – Yahoo Finance

April 24th, 2017 12:43 pm

DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "Russia Diabetes Market Report: 2017 - 2022" report to their offering.

Russia Diabetes Market Report: 2017 - 2022 provides an analytical and statistical insight into the Russia diabetes market. The report provides both current and future trends in the prevalence, demo-graphical breakup, diagnosis and treatment of diabetes in Russia.

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Russia diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Russia diabetes market in any form.

Scope of the Report:

Comprehensive situation analysis of the Russia diabetes epidemiology and its dynamics:

Comprehensive situation analysis of the Russian Oral Antidiabetics market and its dynamics:

Comprehensive situation analysis of the Russian Insulin market and its dynamics:

Key Topics Covered:

1 Preface

2 Research Methodology

3 Executive Summary

4 Introduction

5 Diabetes Disease Overview

6 Russia Diabetes Epidemiology

7 Russia Diabetes Market

For more information about this report visit http://www.researchandmarkets.com/research/633bdx/russia_diabetes

View source version on businesswire.com: http://www.businesswire.com/news/home/20170424005826/en/

The rest is here:
Russia Diabetes Market Report: 2017 - 2022 - Research and Markets - Yahoo Finance

Read More...

Reversing Gene Damage to Treat Blindness | Technology Networks – Technology Networks

April 24th, 2017 12:42 pm

Confocal micrograph of mouse retina depicting optic fiber layer. Image courtesy of National Center for Microscopy and Imaging Research, UC San Diego.

Using the gene-editing tool CRISPR/Cas9, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, have reprogrammed mutated rod photoreceptors to become functioning cone photoreceptors, reversing cellular degeneration and restoring visual function in two mouse models of retinitis pigmentosa.

The findings are published in the April 21 advance online issue of Cell Research.

Retinitis pigmentosa (RP) is a group of inherited vision disorders caused by numerous mutations in more than 60 genes. The mutations affect the eyes photoreceptors, specialized cells in the retina that sense and convert light images into electrical signals sent to the brain. There are two types: rod cells that function for night vision and peripheral vision, and cone cells that provide central vision (visual acuity) and discern color. The human retina typically contains 120 million rod cells and 6 million cone cells.

In RP, which affects approximately 100,000 Americans and 1 in 4,000 persons worldwide, rod-specific genetic mutations cause rod photoreceptor cells to dysfunction and degenerate over time. Initial symptoms are loss of peripheral and night vision, followed by diminished visual acuity and color perception as cone cells also begin to fail and die. There is no treatment for RP. The eventual result may be legal blindness.

In their published research, a team led by senior author Kang Zhang, MD, PhD, chief of ophthalmic genetics, founding director of the Institute for Genomic Medicine and co-director of biomaterials and tissue engineering at the Institute of Engineering in Medicine, both at UC San Diego School of Medicine, used CRISPR/Cas9 to deactivate a master switch gene called Nrl and a downstream transcription factor called Nr2e3.

CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, allows researchers to target specific stretches of genetic code and edit DNA at precise locations, modifying select gene functions. Deactivating either Nrl or Nr2e3 reprogrammed rod cells to become cone cells.

Cone cells are less vulnerable to the genetic mutations that cause RP, said Zhang. Our strategy was to use gene therapy to make the underlying mutations irrelevant, resulting in the preservation of tissue and vision.

The scientists tested their approach in two different mouse models of RP. In both cases, they found an abundance of reprogrammed cone cells and preserved cellular architecture in the retinas. Electroretinography testing of rod and cone receptors in live mice show improved function.

Zhang said a recent independent study led by Zhijian Wu, PhD, at National Eye Institute, part of the National Institutes of Health, also reached similar conclusions.

The researchers used adeno-associated virus (AAV) to perform the gene therapy, which they said should help advance their work to human clinical trials quicker. AAV is a common cold virus and has been used in many successful gene therapy treatments with a relatively good safely profile, said Zhang. Human clinical trials could be planned soon after completion of preclinical study. There is no treatment for RP so the need is great and pressing. In addition, our approach of reprogramming mutation-sensitive cells to mutation-resistant cells may have broader application to other human diseases, including cancer.

This article has been republished frommaterialsprovided by University of California - San Diego. Note: material may have been edited for length and content. For further information, please contact the cited source.

Reference

Zhu, J., Ming, C., Fu, X., Duan, Y., Hoang, D. A., Rutgard, J., . . . Zhang, K. (2017). Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors. Cell Research. doi:10.1038/cr.2017.57

See the original post:
Reversing Gene Damage to Treat Blindness | Technology Networks - Technology Networks

Read More...

Global Biotechnology Reagents Market to Grow at a CAGR of 10.13% by 2021 – Rising Demand for Ready-to-use … – Yahoo Finance

April 24th, 2017 12:41 pm

DUBLIN, Apr. 24, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Biotechnology Reagents Market 2017-2021" report to their offering.

Research and Markets Logo

The global biotechnology reagents market to grow at a CAGR of 10.13% during the period 2017-2021.

The report, Global Biotechnology Reagents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Ready-to-use reagents help minimize calculation, dilution, and pipetting errors. They reduce the duration of the diagnostic procedure and prevent contamination of samples. These factors have resulted in the demand for ready-to-use reagents among clinical laboratories and hospitals.

According to the report, the biotechnology industry is spending a huge amount on R&D to innovate new techniques and technologies. The companies are more focused to improve the products, their quality, and standards. The biotech companies are majorly spending on protein synthesis, drug assessment, therapeutics, DNA and RNA analysis, and cell culture applications. Biotechnology reagents are used in all the processes.

Further, the report states that biotechnology instruments are often complex and require sophisticated software for various measurement procedures. To operate the instruments and analyze a sample, the user must have a significant level of training with not only the method and the instrument but also the software required to run the analysis and the collection of data.

Key vendors

Other prominent vendors

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by technology

PART 07: Market segmentation by application

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Vendor landscape

PART 13: Key vendor analysis

PART 14: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/dqbbgf/global

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-biotechnology-reagents-market-to-grow-at-a-cagr-of-1013-by-2021---rising-demand-for-ready-to-use-reagents-among-clinical-laboratories--hospitals---research-and-markets-300443626.html

See more here:
Global Biotechnology Reagents Market to Grow at a CAGR of 10.13% by 2021 - Rising Demand for Ready-to-use ... - Yahoo Finance

Read More...

‘Thirsty plants’ to land conservation: How biotechnology helps address developing world’s agricultural challenges – Genetic Literacy Project

April 24th, 2017 12:41 pm

[Editors note:Sarah Evanega holds a doctorate in plant biology from Cornell University, where she is the director of the Alliance for Science and senior associate director for International Programs at the College of Agriculture and Life Sciences.]

Agriculture plays a critical role in food security, political stability, and world peace and yet it leaves a big environmental footprint.

Fortunately, scientific innovationsincluding agricultural biotechnologyare helping us meet these challenges.

The Land Conservation Problem

To feed a growing population without encroaching further onto wild lands, scientists are looking to produce more food on less land. Researchers are exploring such ingenious approaches as increasing the rates by which plants perform photosynthesis: the process of using light, water, and CO2 to produce biomass and food. Ultimately, this may help plants sequester CO2 more efficiently, which could boost yields without increasing cultivated acreage. These applications of genetic engineering are innovative models for helping us to produce more with less.

The Pesticide Problem

Researchers in Bangladesh helped reduce insecticide use by smallholder farmers when they developed a variety of insect-resistant eggplant or brinjal, as it is known in South Asia in 2014. Brinjal that incorporates resistance conferred by bacillus thuringiensis (Bt) required the will of forward-thinking political leaders, such as Bangladesh Agriculture Minister Matia Chowdhury, to get approved and on the market. Now, farmers who used to spray their brinjal as frequently as twice a day have reduced their pesticide use by as much as 80 percent.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:Scientific innovations solving agricultural problems

For more background on the Genetic Literacy Project, read GLP on Wikipedia

See the original post:
'Thirsty plants' to land conservation: How biotechnology helps address developing world's agricultural challenges - Genetic Literacy Project

Read More...

Page 1,054«..1020..1,0531,0541,0551,056..1,0601,070..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick